A Case Study on Drug Prescription for Vascular Dementia in Western and Oriental Medicine |
Choi, Seong-Hun
(Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University)
Cheon, Woo-Hyun (Department of Neurology, College of Oriental Medicine, Daeggu Haany University) Baek, Kyung-Min (Department of Internal Medicine, College of Oriental Medicine, Daeggu Haany University) Han, Chang-Hyun (TKM Information Research Division, Korea Institute of Oriental Medicine) Jeon, Won-Kyung (Center for Herbal Medicine Improvement Research, Korea Institute of Oriental Medicine) Gam, Cheol-Ou (Department of Internal Medicine, College of Oriental Medicine, Dong Eui University) Lee, Young-Joon (Department of Preventive Medicine, College of Oriental Medicine, Daeggu Haany University) |
1 | Roman GC. Vascular dementia : distinguishing characteristics, treatment and prevention. J Am Geriatr Soc. 2003 ; 51 : 296-304. DOI ScienceOn |
2 | 대한치매학회. 치매 임상적 접근. 서울 ; 아카데미아. 2006 : 413-425. |
3 | 최성훈, 구세광, 전우현, 백경민, 한창현, 전원경, 이영준. 피질하 혈관성치매의 진단, 치료 및 예방 : 1례 보고와 함께. 대한예방한의학회지. 2010 ; 14(3) : 63-75. |
4 | Rockwood K. Vascular cognitive impairment and vascular dementia. J Neurol Sci. 2002 ; 203-204 : 23-7. |
5 | Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000 ; 60 : 658-659. |
6 | 김상찬, 김선희, 노승현, 박선동, 변성희, 서부일, 서영배, 외. 방제학. 서울: 영림사. 1999 : 462-464. |
7 | 조맹제. 국내 치매 노인 유병률 현황과 위험요인. 보건복지포럼. 2009 ; 156 : 43-48. |
8 | Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial(MMM 300). Stroke. 2002 ; 33 : 1834-1839. DOI ScienceOn |
9 | 대전대학교 한방병원처방집. 대전 : 한국출판사. 1997 : 118. |
10 | 이상룡, 김보경. 安神淸腦湯이 알츠하이머질환 병태 모델의 생화학적 변화 및 기억에 미치는 영향. 동의생리병리학회지. 2001 ; 15(5) : 708-722. |
11 | 최인선, 민성순, 김종환, 서상호, 박상은, 김영균, 권정남. 補中益氣湯 및 그 加味方을 투여한 중풍환자에 대한 임상적 고찰. 대한한방내과학회지. 2004 ; 25(3) : 388-397. |
12 | Onor ML, Trevisiol M, Aguglia E. Rivastigmine in the treatment of Alzheimer's disease : an update. Clin Interv Aging. 2007 ; 2(1) : 17-32. DOI ScienceOn |
13 | Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia : combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005 ; 20(6) : 338-44. DOI ScienceOn |
14 | Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R ; Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia : positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003 ; 34 (10) : 2323-30. DOI ScienceOn |
15 | Heinrich M, Lee TH. Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol. 2004 ; 92(2-3) : 147-62. DOI |
16 | Santos MD, Alkondon M, Pereira EF et al. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol Pharmacol. 2002 ; 61 : 1222-1234. DOI ScienceOn |
17 | Erkinjuntti T, Kurz A, Gauthier S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : A randomised trial. Lancet 2002 ; 359 : 1283-1290. DOI ScienceOn |
18 | Moretti R, Torre P, Antonello RM et al. Rivastigmine in subcortical vascular dementia : An open 22-month study. J Neurol Sci 2002 ; 203-204 : 141-146. |
19 | Lancelot E, Beal MF. Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res. 1998 ; 116 : 331-347. |